High-quality, pharmaceutical-grade B12
These investigations focus on molecular mechanisms and assay responses exclusively in controlled, non-clinical in-vitro environments
Developed by Eli Lilly, this investigational drug has generated major excitement thanks to clinical trial results showing weight loss that surpasses anything currently available
Nonetheless, therapeutic failure, partly from inability to maximise the dose or persist with the medication because of nausea and vomiting, limits the potential of this class of drugs
Document the prescriber-pharmacist-patient triangulation specific to each prescription
The metabolic improvements achieved during treatment, such as better testosterone levels and reduced insulin resistance in women with PCOS, may reverse after stopping therapy